Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,813 | 63,402 | 56,370 | 51,371 | 28,582 |
| Marketable Securities | 11,764 | 18,145 | 10,114 | 22,406 | 37,225 |
| Receivables | 42,444 | 40,631 | 41,581 | 34,097 | 37,102 |
| Inventories | 23,905 | 23,484 | 20,406 | 20,298 | 16,097 |
| TOTAL | $172,226 | $159,105 | $139,258 | $134,208 | $127,258 |
| Non-Current Assets | |||||
| PPE Net | 467 | 472 | 307 | 453 | 469 |
| Intangibles | 16,836 | 16,836 | 16,836 | 16,836 | 16,836 |
| Other Non-Current Assets | 9,919 | 10,744 | 11,548 | 12,739 | 13,690 |
| TOTAL | $27,222 | $28,052 | $28,691 | $30,028 | $30,995 |
| Total Assets | $199,448 | $187,157 | $167,949 | $164,236 | $158,253 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,010 | N/A | N/A | 273 | N/A |
| Accounts payable and accrued liabilities | 12,581 | 10,114 | 9,116 | 7,328 | 7,917 |
| Accrued Expenses | 44,156 | 42,776 | 40,917 | 40,651 | 33,907 |
| Other current liabilities | N/A | 3,452 | 194 | N/A | 234 |
| TOTAL | $62,487 | $57,065 | $50,933 | $48,834 | $42,783 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 38,736 | 39,383 | 42,946 | 41,554 | 40,807 |
| TOTAL | $38,736 | $39,383 | $42,946 | $41,554 | $40,807 |
| Total Liabilities | $101,223 | $96,448 | $93,879 | $90,388 | $83,590 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,657 | 97,098 | 96,739 | 96,629 | 96,362 |
| Common Shares | 972 | 967 | 966 | 965 | 963 |
| Retained earnings | -789,562 | -789,582 | -799,247 | -794,328 | -789,285 |
| Other shareholders' equity | -23,576 | -23,646 | -24,312 | -24,580 | -23,802 |
| TOTAL | $98,225 | $90,709 | $74,070 | $73,848 | $74,663 |
| Total Liabilities And Equity | $199,448 | $187,157 | $167,949 | $164,236 | $158,253 |